Table 3.
Blood Pressure Outcome (n=1329) |
Z-score Increment, Systolic Blood Pressure |
Z-score Increment, Diastolic Blood Pressure |
Odds Ratio, Blood Pressure ≥90th Percentile |
---|---|---|---|
LMW Metabolites | +0.02 (−0.05, +0.10) | +0.04 (−0.16, +0.24) | 1.12 (0.79, 1.59) |
HMW Metabolites | +0.12 (+0.03, +0.21)† | +0.06 (−0.03, +0.16) | 1.30 (0.78, 2.17) |
DEHP Metabolites | +0.10 (+0.03, +0.18)* | +0.09 (+0.04, +0.17)* | 1.31 (0.90, 1.91) |
DIDP Metabolites | +0.11 (+0.04, +0.17)† | +0.03 (−0.04, +0.10) | 0.99 (0.66, 1.48) |
DINP Metabolites | +0.11 (+0.03, +0.19)† | +0.02 (−0.09, +0.13) | 1.19 (0.72, 1.98) |
Triglyceride Outcome (n=350) | Odds Ratio, Elevated Triglycerides | Increment, Triglycerides | |
LMW Metabolites | 0.83 (0.62, 1.12) | −0.04 (−0.10, +0.007) | |
HMW Metabolites | 1.07 (0.81, 1.42) | −0.008 (−0.06, +0.04) | |
DEHP Metabolites | 0.91 (0.69, 1.19) | −0.02 (−0.07, +0.03) | |
DIDP Metabolites | 1.01 (0.76, 1.36) | −0.01 (−0.06, +0.04) | |
DINP Metabolites | 1.19 (0.97, 1.47) | +0.005 (−0.03, +0.04) | |
HDL Outcome (n=1186) | Odds Ratio, Low HDL | Increment, HDL | |
LMW Metabolites | 1.17 (0.81, 1.71) | +0.46 (−0.57, +1.50) | |
HMW Metabolites | 0.93 (0.66, 1.32) | +0.98 (−0.25, +2.20) | |
DEHP Metabolites | 0.89 (0.58, 1.36) | +1.20 (−0.17, +2.58) | |
DIDP Metabolites | 0.97 (0.77, 1.23) | −0.11 (−1.56, +1.33) | |
DINP Metabolites | 0.89 (0.74, 1.05) | +0.47 (−0.46, +1.40) |
Increases are per log unit in urinary LMW/HMW/DEHP/DINP/DIDP metabolite concentration. See methods for calculation.
Models control for gender, caloric intake, physical activity, poverty-income ratio, serum cotinine, urinary creatinine, BMI category, race/ethnicity and age categories.
Results using weighted modeling are presented here for blood pressure and HDL outcomes; trygliceride outcome results are presented unweighted (see methods).
p <0.05
p <0.01
p<0.001